2006 Ontario Survey on the Prevalence and Control of Hypertension (ON-BP): Rationale and design of a community-based cross-sectional survey

Canadian Journal of Cardiology

Volumn 24, Issue 6, 2008, Pages 503-505

  Fodor, J George ^a   Leenen, Frans H H ^a   Helis, Eftyhia ^a   Turton, Penelope ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Epidemiology; Hypertension

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CANADA; COMMUNITY SAMPLE; COMORBIDITY; DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; HEALTH CARE ORGANIZATION; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; POPULATION RESEARCH; PREVALENCE; SEX; SOCIAL STATUS; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY;

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ONTARIO; PILOT PROJECTS; POPULATION SURVEILLANCE; PREVALENCE;

EID: 46249129157     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70626-3     Document Type: Article

References (20)

1. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
2. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: A systematic review. J Hypertens 2004;22:11-9.
3. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9. (Erratum in 1996;27:1192).
4. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
5. Cífková R, Skodová Z, Lánská V, et al. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. J Hypertens 2004;22:1479-85.
6. Ministry of Health and Long-Term Care. 2004 Chief Medical Officer of Health Report: Healthy weights, healthy lives. (Version current at May 6, 2008).
7. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet 2007;369:750-6.
8. Statistics Canada. Community profiles 2001, 2006. (Version current at May 6, 2008).
9. Richardson G, Godfrey L, Gravelle H, Watt I. Cost-effectiveness of implementing new guidelines for treatment of hypertension in general practice. Br J Gen Pract 2004;54:765-71.
10. Vijgen SM, Hoogendoorn M, Baan CA, de Wit GA, Limburg W, Feenstra TL. Cost effectiveness of preventive interventions in type 2 diabetes mellitus: A systematic literature review. Pharmacoeconomics 2006;24:425-41.
11. Grover SA, Coupal L, Kaouache M, Lowensteyn I. Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia? Can J Cardiol 2007;23:467-73.
12. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C. Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ 1996;313:147.
13. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 1992;146:1997-2005.
14. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10:1097-102.
15. Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, betablockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001;14:241-7.
16. Neutel CI, Campbell NR. Antihypertensive medication use by recently diagnosed hypertensive Canadians. Can J Cardiol 2007;23:561-5.
17. Houweling ST, Kleefstra N, Lutgers HL, Groenier KH, Meyboom-de Jong B, Bilo HJ. Pitfalls in blood pressure measurement in daily practice. Fam Pract 2006;23:20-7.
18. Graves JW, Sheps SG. Does evidence-based medicine suggest that physicians should not be measuring blood pressure in the hypertensive patient? Am J Hypertens 2004;17:354-60.
19. Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens 2008;21:280-3.
20. Leenen FH, Dumais J, McInnis N, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008;178:1441-9.